BIOMEDICAL TECHNOLOGY
Abstract
This Program Element is budgeted in the applied research budget activity because it focuses on medical related technology, information, processes, materials, systems, and devices encompassing a broad spectrum of DoD challenges. Biowarfare defense includes the capability to predict and deflect pathogen evolution of natural and engineered emerging threats and therapeutics that increase survivability within days of receipt of an unknown pathogen. Continued understanding of infection biomarkers will lead to developing a detection device that can be self-administered and provide a faster ability to diagnose and prevent widespread infection in-theater. Other battlefield technologies includes a soldier-portable hemostatic wound treatment system, capability to manufacture field-relevant pharmaceuticals in theater, and a rapid after-action review of field events as a diagnostic tool for improving the delivery of medical care and medical personnel protection. Improved medical imaging will be approached through new physical properties of cellular metabolic activities. New neural interface technologies will reliably extract information from the nervous system to enable control of the best robotic prosthetic-limb technology. To allow medical practitioners the capability to visualize and comprehend the complex relationships across patient data in the electronic medical record systems, technologies will be developed to assimilate and analyze the large amount of data and provide tools to make better informed decisions for patient care. In the area of medical training, new simulation-based tools will rapidly teach increased competency in an open and scalable architecture to be used by all levels of medical personnel for basic and advanced training. Advanced information-based techniques will be developed to supplement warfighter healthcare and the diagnosis of post-traumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI). This project will also pursue the applied research efforts for dialysis-like therapeutics.
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2014
- Source ID
- 0602115E_2_0400_PB_2014
- Change Summary Explanation
- FY 2012: Increase reflects an internal below threshold reprogramming offset by the SBIR/STTR transfer. FY 2014: Increase reflects planned expansion of the Dialysis-like Therapeutics and ADEPT programs.
- Service Agency Name
- Defense Advanced Research Projects Agency
Entities
Organizations
- Defense Advanced Research Projects Agency
Related Documents
- Child Project: BIOMEDICAL TECHNOLOGY
- Child Accomplishment: Pathogen Defeat
- Child Accomplishment: Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT)
- Child Accomplishment: Tactical Biomedical Technologies
- Child Accomplishment: Military Medical Imaging
- Child Accomplishment: Dialysis-Like Therapeutics
- Child Accomplishment: Warrior Web
- Child Accomplishment: Revolutionizing Prosthetics*
- Child Accomplishment: Restoration of Brain Function Following Trauma
- Child Accomplishment: Translational Understanding of Blast Effects (TransBlast)
- Child Accomplishment: Detection and Computational Analysis of Psychological Signals (DCAPS) - Medical*
- Child Accomplishment: Unconventional Therapeutics
- Child Accomplishment: Reliable Neural-Interface Technology (RE-NET)
- Child Accomplishment: Preventing Violent Explosive Neurologic Trauma (PREVENT)